>>> Exxon Mobil beats by $0.08, misses on revs; Earnings rise 122% year/year to

Exxon Mobil beats by $0.08, misses on revs; Earnings rise 122% year/year to $4.0 bln with solid results from all segments (81.26)
  • Reports Q1 (Mar) earnings of $0.95 per share, $0.08 better than the Capital IQ Consensus of $0.87; revenues rose 29.9% year/year to $63.29 bln vs the $64.88 bln Capital IQ Consensus.
Upstream:
  • Upstream earnings were $2.3 bln, compared to a loss of $76 mln in the first quarter of 2016
  • Upstream volumes were 4.2 mln oil-equivalent barrels per day, a decline of 4 percent compared with the prior year, primarily due to the impact of lower entitlements due to increasing prices, and higher maintenance
  • Higher liquids and gas realizations increased earnings by $2.3 bln. Lower volume and mix effects decreased earnings by $150 mln
  • All other items increased earnings by $170 mln primarily as a result of lower expenses.
  • On an oil-equivalent basis, production decreased 4% from the first quarter of 2016
  • Liquids production of 2.3 mln barrels per day decreased 205,000 barrels per day due to lower entitlements and higher maintenance activity mainly in Canada and Nigeria
  • Natural gas production of 10.9 bln cubic feet per day increased 184 mln cubic feet per day from 2016 as project ramp-up was partly offset by field decline.
  • U.S. Upstream earnings were a loss of $18 mln, compared to a loss of $832 mln in the first quarter of 2016. Non-U.S.
  • Upstream earnings were $2.3 bln, up $1.5 bln from the prior year.
Downstream:
  • Downstream earnings were $1.1 bln, up $210 mln from the first quarter of 2016
  • Higher margins increased earnings by $10 mln
  • Volume and mix effects increased earnings by $160 mln
  • All other items increased earnings by $40 mln
  • Petroleum product sales of 5.4 mln barrels per day were 61,000 barrels per day higher than last year's first quarter
  • Earnings from the U.S. Downstream were $292 mln, up $105 mln from the first quarter of 2016
  • Non-U.S. Downstream earnings of $824 mln were $105 mln higher than last year
Chemical earnings of $1.2 bln were $184 mln lower than the first quarter of 2016. Weaker margins decreased earnings by $70 mln

>>> Royal Caribbean beats by $0.06, reports revs in-line; guides FY17 EPS in-lin

Royal Caribbean beats by $0.06, reports revs in-line; guides FY17 EPS in-line (100.50)
  • Reports Q1 (Mar) earnings of $0.99 per share, excluding non-recurring items, $0.06 better than the Capital IQ Consensus of $0.93; revenues rose 4.7% year/year to $2.01 bln vs the $2.02 bln Capital IQ Consensus.
  • Co issues in-line guidance for FY17, sees EPS of $7.00-7.20 (Prior $6.90-7.10), excluding non-recurring items, vs. $7.07 Capital IQ Consensus Estimate.
    • Overall, the company's booked position remains at a record level, better than last year on both a rate and volume basis.
    • Net Yields are expected to increase 4.5% to 6.0% on a Constant-Currency basis (up 4.0% to 5.5% As-Reported).
    • NCC excluding fuel are expected to be flat to up slightly on a Constant-Currency basis (flat As-Reported).
  • Outlook
  • Looking at the year as a whole, the company's expectations remain largely unchanged from the guidance it provided 3 months ago:
    • Bookings, overall, are not materially different, with strength in Europe offsetting the impact of Korea;
    • Currency and fuel are not materially different;
    • Costs continue to be under control;
    • First quarter results are the key drivers of the upward guidance revision for the full year

>>> Goodyear Tire beats by $0.11, misses on revs / no premarket yet

Goodyear Tire beats by $0.11, misses on revs (35.45)
  • Reports Q1 (Mar) earnings of $0.74 per share, excluding non-recurring items, $0.11 better than the Capital IQ Consensus of $0.63; revenues rose 0.2% year/year to $3.70 bln vs the $3.78 bln Capital IQ Consensus.
  • "These results are a great outcome given an environment of rising raw material costs and weaker demand...While raw material inflation has moderated in recent weeks, we continue to expect a significant year-over-year headwind in 2017."
  • Co confirms its 2017 segment operating income guidance of approximately $2.0 bln and its 2020 financial targets and capital allocation plan.

>>> Alphabet A: Color on Qtr --> GOOG +4.2% - All time High

Alphabet A: Color on Qtr (891.44)
  • Pivotal Research notes Alphabet reported another quarter featuring better-than-expected metrics on revenue growth, expense management and capital expenditures. Longer-term expectations are raised slightly. Firm continues to rate the stock Hold. Company provided new disclosures on regional revenue breakouts. On a constant currency basis, the US (48% of revenue) rose by +25%, EMEA (33% of revenues) grew by +19%, APAC (15% of revenues) expanded by +26% and Other Americas outside of the US (5% of revenues) gained +29%. As a subset of EMEA revenues, the UK (8% of total revenues) was up +16%. Looking at costs, TAC to network members rose to represent 70.5% of network revenue -- marginally higher vs. recent levels, but still the highest for any quarter since 2009.
  • RBC Capital raises tgt to $1050 from $1025. Key Positives were: a) Impressive top-line growth, b) Stabilization in Core Google Operating Margins, and c) $1.1B Share Repo. Q1 Keys: (1) Robust & Consistent Revenue Growth: 24% Y/Y Organic Rev growth matched Q4's robust rate, while 20% Y/Y Ad growth (ex-FX) accelerated 1pt. (2) Expanding Op Margin: Non-GAAP Op Margin of 42.6% was up 110bps Y/Y, while GAAP Op Margin was up 20bps Y/Y to 32.6% despite the increased SBC. (3) Mobile Impacts Clicks & CPCs: 44% Y/Y Paid Click growth is the highest in a decade with particular strength in Google Sites (record-high 53% Y/Y); overall CPCs, however, decline of (19%) Y/Y. (4) Higher Overall TAC: 10.4% of Google Sites (up 60bps Q/Q) was a new high, as was the 70.5% at Network (up 90bps Q/Q); overall TAC remained at 21.6% of Total Ad Rev. This was the negative.
  • Wedbush raises tgt to $725 from $700. Solid beat in seasonally small 1Q takes up firm's estimates and PT, but Sites TAC pressures keep building, and results are too early to reflect traction of newer ad products of an AMZN or quality challenges for YouTube in pulling from TV. Recent advertiser pullbacks from YouTube were likely too recent to affect 1Q growth, and, more importantly, its progress against TV depends more on upcoming advertiser negotiations. Wedbush's view remains that incursions by other FAANG companies into search are likely to have a detectible impact by 2018.

>>> Amazon: Color on Quarter -->+3.5% @ 950 - All time high

Amazon: Color on Quarter (918.38)
  • RBC Capital Mkts raises their AMZN tgt to $1100 from $900. AMZN posted strong Q1 results, with Revenue and Operating Income coming in ahead of Street expectations & Q2 guidance bracketing the Street. Fundamentals remain very much intact as the company continues to invest aggressively.
  • Wedbush notes Amazon continues to deliver substantial earnings growth, tempered somewhat by spending on new initiatives. Amazon appears intent upon growing annual profits (with some quarterly volatility), which we expect to continue as the co invests in growth. Amazon Web Services (AWS), Fulfillment by Amazon (FBA), and advertising should continue to drive growth and at high margin. As a result, they expect gross and operating margins to continue expanding rapidly. They expect international Prime membership growth to drive overall retail revenue, particularly as Amazon is rapidly expanding in India. Operating margin expansion will likely be tempered somewhat by increased spending on video content, fulfillment, and international expansion; however, the trajectory is clear and the company's investment strategy purposeful.
  • Maxim raises tgt to $1075 from 100 after impressive top and bottom line results.
  • KeyBanc/Pacific Crest downgraded to Sector Weight -- As good as it gets (for now); stepped-up competition may dampen near-term upside

>>> US Early premarket gappers

Early premarket gappers
Gapping up: ALGN +13.2%, EHTH +8.7%, WDC +8.4%, SYNA +7.6%,TRMB +7.3%, BJRI +7.2%, LPLA +6.8%, SWN +6.1%, MDXG +5.7%, PER+4.8%, HON +4.7%, MOBL +4.5%, CERN +4.1%, GOOG +4%, ZEUS +4%,UBS +3.9%, TRVG +3.8%, AMZN +3.7%, HLS +3.4%, IDXX +3.4%, RBS+3.4%, CNHI +3.3%, DELT +3.1%, VRTX +3.1%, SMCI +2.9%, APO+2.9%, CEI +2.8%, MT +2.7%, MMSI +2.6%, SAN +2.3%, SNE +2.3%,VDSI +2.2%, BRKS +2.2%, VALE +2.1%, MU +2.1%, AVHI +2.1%, ASX+2.1%, RIO +1.9%, LYB +1.8%, RIG +1.7%, BBL +1.7%, TEAM +1.6%,GPRO +1.6%, SNY +1.6%, WETF +1.6%, GFI +1.5%, AMD +1.5%, GLPG+1.5%, NOK +1.4%, FB +1.4%, WFT +1.4%, BLDP +1.3%, BHP +1.3%,ABX +1.3%, STM +1.3%, SBGL +1.2%, PSX +1.2%, TRI +1.2%, RXDX+1.1%, PXLW +1.1%, GDX +1%, FHB +1%, AEM +1%, SIMO +1%

Gapping down: CRMD -37.5%, FCEL -21.9%, CYTR -18.2%, ATHN-16.8%, GIMO -16%, CLD -15%, TRXC -11.9%, PCMI -11.1%, VCRA-11.1%, MTRX -10.2%, ARAY -9.8%, TNDM -9.5%, ELLI -9.2%, ORC-8.4%, FTNT -7.2%, RMD -6.5%, SYF -6.2%, GHL -5.1%, BCS -5%, STAY-4.6%, SBUX -4.6%, TMST -4.5%, INTC -3.8%, ABAX -3.7%, KLAC-3.5%, CL -3.3%, FLEX -3.2%, CYTK -3.2%, ATEN -3.1%, MHK -2.9%,SWKS -2.7%, BIDU -2.5%, NXPI -2.4%, EXPE -2%, RGA -1.5%, CSL-1.4%, SRPT -1.4%, COHU -1.3%, APAM -0.7%, HRC -0.7%, FII -0.6%,VRSN -0.6%, VFC -0.6%, PFG -0.5%, KBR -0.5%

>>> Colgate comments - slowing growth

RTRS - COLGATE-PALMOLIVE CO - Q1 WAS "CHALLENGING" AND DID NOT MEET OUR ORGANIC SALES GROWTH EXPECTATIONS, DRIVEN MAINLY BY "SOFTER" RESULTS IN NORTH AMERICA
RTRS - COLGATE-PALMOLIVE CO - "AS WE LOOK AHEAD, UNCERTAINTY IN GLOBAL MARKETS AND SLOWING CATEGORY GROWTH WORLDWIDE REMAIN CHALLENGING"

MAKOR MERGER ARBITRAGE COMMENT - ZC FP / SAF FP - OUR THOUGHTS ON ZODIAC'S H

April 28, 2017 

 

MAKOR MERGER ARBITRAGE COMMENT - ZC FP / SAF FP - OUR THOUGHTS ON ZODIAC'S H1 RESULTS

 

Zodiac continues to be very supportive of a deal with Safran and have said that they have provided Safran with all the additional required information and now the decision remains up to Safran whether or not a transaction is ultimately reached. A transaction with Safran is Zodiac’s preferred strategy although they reiterated that they also have very good standalone prospects which Zodiac have strong confidence in. Zodiac is expected to operate under “normal conditions” by the end of 2017.

 

Zodiac reported better H2 guidance aided by a ramp-up of electrical systems activity, a strong order book in Data Systems to deliver in H2 and their “Restore Margin” action plan. Zodiac have pushed back their double digits margins target to 2019 from 2018 and reiterated its target of a “mid-double digit” current operating margin by fiscal year 2018/2019. Zodiac expect to fully eliminate disruption costs by end FY19. FY 16/17 COI is now estimated between €200m and €220m.

 

In the call this morning, Zodiac denied the need for a rights issue. They also stated that their banking covenant is to be respected at year end and medium-term financing has been fully secured.

 

We remain convinced by the strong strategic rationale for Zodiac and Safran to do a deal. We also note the comments from TCI reiterating that Safran is overpaying for Zodiac. While a small reduction (c.10%) in the mooted €29.47 offer price could be warranted we note that the families are highly unlikely to accept a significant reduction in the Offer Price. The Domange family has commented that they are expecting the Safran offer in c.1month and that they see a Zodiac improvement in a few quarters and that Zodiac has not lost the trust of most of its clients.

 

Zodiac continues to battle industrial issues particularly in their seats branch which they say are currently being addressed. Zodiac Seats US is back to its normal operational performance but Zodiac Seats UK should return to normal performance by December 2017 as Zodiac have transferred their production to other Group facilities (however this has resulted in cost penalties).

 

 

 

  

  ​     ​     ​

 

Makor Capital

 

11 Menachem Begin St., 26th FL

Ramat Gan 52681
ISRAEL
Tel         +972 3 5453 762

Fax        +972 3 7162 680

 

   

Research Disclaimer

 

This publication has been prepared by Makor Capital Limited (“Makor Capital”) and is intended for professional or qualified investors only. Makor Securities London Ltd (“Makor Securities”)is distributing this material to its clients who are Eligible Counterparties or Professional Clients under FCA Rules. It may also be disseminated to persons who are Investment Professionals within the meaning of the Financial Services and Markets Act 2000 (Financial Promotion Order 2005).  In the United States, Makor Capital only distributes this material to major US institutional investors (as that term is defined in Rule 15a-6 of the Securities and Exchange Act of 1934) and to SEC-registered broker-dealers or  banks acting in a broker–dealer capacity. This material is not intended for distribution to any other persons and should not be redistributed.  If you do not fall into any of these categories you should disregard it.

 

This material is a marketing communication.  It is not investment research and has not been prepared in accordance with legal requirements designed to promote the independence of investment research. It is not subject to any prohibition on dealing ahead of the dissemination of investment research under U.K. law. This material is not a research report and is not intended to be a research report as defined under U.S. securities laws and regulations.  This material is not intended to provide information reasonably sufficient upon which to base any investment decision.   

 

This material does not take into account the particular investment objectives, financial situation or needs of individual clients or other recipients. Before acting on this material, clients and other recipients should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. 

 

This material should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. 

 

In the United States, Makor Capital does not offer securities services to U.S. persons except pursuant to SEC Rule 15a-6 only to major US institutional investors and SEC registered broker-dealers or  banks acting in a broker–dealer capacity. Transactions in the United States must be effected through the U.S. broker-dealer, Oscar Gruss & Son Incorporated. Oscar Gruss & Son has not prepared, reviewed or distributed this material.

 

Some of this material is produced by providers which Makor Securities believes to be reliable, but Makor Securities does not warrant or represent (expressly or impliedly) that it is accurate, complete, not misleading or as to its fitness for the purpose intended and it should not be relied upon as such. 

Opinions expressed will be the current opinions of those producing this material as of the date appearing on this material only. We expect those producing the material in  this publication to update it on a timely basis but can give no undertaking that they will do so and regulatory compliance or other reasons may prevent  them from doing so (or us from disseminating updated material).  

 

Members and employees of Makor Securities London Ltd, employees of Makor Capital, Makor Capital Markets may from time to time have long or short positions in securities, warrants, futures, options, derivatives or other financial instruments referred to in this material. For Makor Securities, this information is set out in our Conflicts of Interest Policy which is available on request.  Policies for the production of research from other research providers are available on request.  Unless otherwise stated, share prices provided within this material are as at the close of business on the day prior to the date of the material.

 

Neither the whole nor any part of this material may be duplicated in any form or by any means. Neither should any of this material be redistributed or disclosed to anyone without prior consent. This material is issued for general information and discussion purposes only. None of  Makor Securities, Makor Capital, Makor Capital Markets accepts  liability whatsoever for any direct, indirect or consequential loss or damage of any kind arising out of the use of all or any of this material. 

 

The services, securities and investments discussed in this material may not be available to, nor are suitable for all investors. Investors should make their own investment decisions based upon their own financial objectives and financial resources and it should be noted that investment involves risk, including the risk of capital loss. Past performance is no guide to future performance. In relation to securities denominated in foreign currency, movements in exchange rates will have an effect on the value, either favourable or unfavourable.

 

All investors. Investors should make their own investment decisions based upon their own financial objectives and financial resources and it should be noted that investment involves risk, including the risk of capital loss. Past performance is no guide to future performance. In relation to securities denominated in foreign currency, movements in exchange rates will have an effect on the value, either favourable or unfavourable.

 

Entities

 

Makor Securities London Ltd is authorised and regulated by the Financial Conduct

Authority (FCA registration number 625054) 

 

Makor Capital, company number 514456466, is incorporated in Israel and is a 100% held

subsidiary of Makor Holdings Pte Ltd incorporated in Singapore. 

 

Makor Capital Markets SA, company number CH-660.2.999.011-0 is incorporated in Switzerland

and is also a 100% held subsidiary of Makor Holdings Pte Ltd.

 

 

Having trouble viewing this email? Click here


This email was sent to lchekroun@makor-cm.com by Research@Makor-Capital.com

Update Profile/Email Address | Unsubscribe | Report abuse


 Smoove email marketing

 

Reuters - Akzo Nobel investor USS backs call for PPG talks over revised bid

One of Britain's biggest pension scheme investors has called on Dutch paintmaker Akzo Nobel to engage with U.S. suitor PPG Industries over a revised bid and criticized the board's handling of the issue.

The Universities Superannuation Scheme, which manages around 57 billion pounds ($73.66 billion) on behalf of 375,000 savers, said a revised $29 billion bid for Akzo from PPG was enough for "meaningful and constructive" dialogue to begin "in earnest".

After rejecting two previous bids, Akzo has yet to respond to the third. At the firm's annual meeting on Tuesday, it refused a request from a group of shareholders to hold an extraordinary general meeting to discuss the bid.

Daniel Summerfield, Co-Head of Responsible Investment at USS, said the decision to refuse the EGM request "not only undermines the credibility of the board but portrays Dutch governance in a very negative light".

USS said in a statement that it had been a shareholder in Akzo Nobel since 2010 and currently held a 1.28 percent stake in Akzo, making it a top-10 investor according to Thomson Reuters data.